EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria

Michael Gilligan, Smathorn Thakolwiboon iD, Emma Orozco, Samantha Banks iD, Eoin P Flanagan, Sebastian Lopez-Chiriboga iD, Jan-Mendelt Tillema, John R Mills, Sean J Pittock iD, Cristina Valencia Sanchez iD, Anastasia Zekeridou iD, Divyanshu Dubey iD und 1 weitere

Annals of Clinical and Translational Neurology · 2025-01 · 12 (1) · 213-225

DOI: 10.1002/acn3.52273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 21.12.2024. Verfasst von Michael Gilligan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Brain Stem, Encephalitis, Autoantibodies, Autoimmune Diseases of the Nervous System. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Irish Clinical Academic Training (ICAT), National Institutes of Health, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We describe neurologic phenotype, clinical associations, and outcomes in autoimmune brainstem encephalitis.

Methods

Medical records of neural‐IgG positive autoimmune brainstem encephalitis patients diagnosed at Mayo Clinic (January 1, 2006–December 31, 2022) were reviewed.

Results

Ninety‐eight patients (57 male) were included. Median age of symptom onset was 51 years (range, 8 months‐85 years). Frequent presenting features were ≥1: diplopia (80%), ataxia (78%), dysarthria (68%), vestibulocochlear symptoms (67%), dysphagia (61%), nausea/vomiting (42%), and facial weakness (32%). Altered mental status (11%) was uncommon. Neural antibodies detected were as follows: KLHL‐11 (26 patients), GAD65 (high titer, 12), ANNA‐1 (anti‐Hu, 8), ANNA‐2 (anti‐Ri, 8), Ma2 (7), IgLON‐5 (6), AQP4 (6), MOG (4), glycine receptor (4), GQ1B (4), PCA‐1 (anti‐Yo, 4), DPPX (2), neurochondrin (2), neurofilament (2), NMDA‐R (2), AGNA‐1 (SOX‐1, 1), ANNA‐3 (DACH1, 1), amphiphysin (1), CRMP‐5 (1), ITPR‐1 (1), PCA‐Tr (DNER, 1), and PDE10A (1). Cancer was identified in 55 patients: germ cell (23 patients; 3 extra‐testicular), ductal breast adenocarcinoma (8), small cell carcinoma (6, lung 4), adenocarcinomas (6), neuroendocrine carcinoma (3), hematologic (2), squamous cell (2), and other (7). Median modified Ranking score (mRS) at last follow‐up was 3 (range, 0–6). Factors associated with poor outcome included abnormal brain MRI, bulbar symptoms, and elevated CSF IgG index. Kaplan–Meier analysis revealed faster progression to wheelchair in patients who were immunotherapy refractory and with elevated CSF IgG index. Diagnostic criteria for autoimmune brainstem encephalitis (definite and probable) are proposed.

Interpretation

Autoimmune brainstem encephalitis is a distinct clinical subphenotype of autoimmune encephalitis. Abnormal brain MRI, bulbar symptoms, and elevated CSF‐IgG index associate with poor outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain StemEncephalitisAutoantibodiesAutoimmune Diseases of the Nervous SystemHashimoto DiseaseHumansMaleFemaleMiddle AgedAdultAgedAdolescentYoung AdultAged, 80 and overChildChild, PreschoolInfantRetrospective Studies

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • St Vincent's Hospital, University College Dublin, Elm Park, Dublin, Ireland.
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Smathorn Thakolwiboon, Samantha Banks, Sebastian Lopez-Chiriboga, Sean J Pittock, Cristina Valencia Sanchez, Anastasia Zekeridou, Divyanshu Dubey, Andrew McKeon

Förderung

  • NINDS NIH HHS
  • Irish Clinical Academic Training (ICAT)
  • National Institutes of Health, USA
  • Wellcome Trust
  • Canadian Institute for Theoretical Astrophysics

Zitieren

APA

Gilligan, M., Thakolwiboon, S., Orozco, E., Banks, S., Flanagan, E. P., Lopez-Chiriboga, S., Tillema, J. M., Mills, J. R., Pittock, S. J., Valencia Sanchez, C., Zekeridou, A., Dubey, D., & McKeon, A. (2025). Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria. Annals of Clinical and Translational Neurology, 12(1), 213-225. https://doi.org/10.1002/acn3.52273

Vancouver

Gilligan M, Thakolwiboon S, Orozco E, Banks S, Flanagan EP, Lopez-Chiriboga S, et al. Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria. Annals of Clinical and Translational Neurology. 2025;12(1):213-225. doi:10.1002/acn3.52273

BibTeX
@article{Gilligan2025,
  author = {Gilligan, Michael and Thakolwiboon, Smathorn and Orozco, Emma and Banks, Samantha and Flanagan, Eoin P and Lopez-Chiriboga, Sebastian and Tillema, Jan-Mendelt and Mills, John R and Pittock, Sean J and Valencia Sanchez, Cristina and Zekeridou, Anastasia and Dubey, Divyanshu and McKeon, Andrew},
  title = {Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  volume = {12},
  number = {1},
  pages = {213--225},
  doi = {10.1002/acn3.52273}
}
Kostenlos starten →